agilon health, inc. revised financial guidance for the fiscal year 2023. For the period, the company provided revenue guidance low of $4,310 million and high of $4,320 million compared to previous guidance low of $4,525 million and high of $4,540 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.29 USD | +2.28% | +5.54% | -49.88% |
Jul. 10 | Agilon Health Appoints Karthik Rao as Chief Medical Officer | MT |
Jul. 10 | Agilon health, inc. Appoints Karthik Rao, M.D., as Chief Medical Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.88% | 2.59B | |
-25.23% | 2.52B | |
-36.27% | 2.35B | |
-38.58% | 265M | |
+1.73% | 226M | |
-29.61% | 122M | |
-63.73% | 119M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Revises Financial Guidance for the Fiscal Year 2023